Indefinite Delivery Contract 36C26324D0041

Award Date 2/7/24
Last Date to Order 9/30/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a single-award Indefinite Delivery Contract (IDC) to Pine Pharmaceuticals LLC, an FDA-registered 503B outsourcing facility, to provide 503B compounding pharmaceutical products and services. The $136,800 IDC has an ultimate completion date of September 30, 2025. Under this IDC, the VA VHA has issued two firm-fixed price delivery orders totaling $136,800. The first order, valued at $68,400, was awarded on...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide nationwide pharmacy compounding services. The contract has a ceiling value of $10,000,000 and a period of performance through October 31, 2025. Under this IDC, Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) will provide highly specialized pharmaceutical...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) has awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for the provision of hazardous sterile compounding services. The contract, valued at $2,433,675.00, has a period of performance through October 1, 2024 and was awarded without any set-aside designation, indicating it was a full and open commercial competition. Under this IDC, the VA-VHA has...
The key products and services being delivered under this federal contract IDV award are specialized pharmacy services and hazardous compounding for chemotherapy and other intravenous medications to support the Department of Veterans Affairs (VA) healthcare system. The prime contractor, Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated, has been awarded a single-award Indefinite Delivery Contract (IDC) worth $6.75 million by...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C. to provide pharmaceutical products and medical supplies to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The $6,509,967.70 contract, effective from September 15, 2021 through September 14, 2025, was issued without a set-aside designation. The contract aims to ensure an uninterrupted...
The Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide nationwide pharmacy compounding services. The $800,000 IDC has a 5-year ordering period and allows the VA to issue delivery orders for Optum Pharmacy 801, Inc. to compound customized chemotherapy agents, hazardous sterile preparations, intravenous solutions, and other medications to support VA oncology and infusion...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 (VISN 6), a civilian agency, to Nationwide Pharmaceutical LLC, doing business as Medical Wholesale, a veteran-owned and service-disabled veteran-owned small business. The $532,500 IDC, with a completion date of February 28, 2025, is for providing first-fill emergency pharmacy services to support the VA healthcare delivery mission. Under this IDC, Nationwide...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $4,999,999.00, awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valid through December 2036, covers the procurement of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities...
This Federal Supply Schedule contract awards Pacira Pharmaceuticals, Inc. as the prime contractor to provide the Department of Veterans Affairs (VA) with a range of drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The multiple-award, indefinite-delivery/indefinite-quantity (IDIQ) contract has a total potential value of $93,582,250 over the 5-year period of performance from September 2022 to August 2027. As the prime, Pacira Pharmaceuticals will deliver the contracted...
This federal contract IDV award is a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 2 and Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The single-award BPA, valued at up to $1,415,000, provides chemo compounding services to support the VA's oncology and infusion treatment programs when the agency's on-site compounding capabilities are temporarily unavailable. The contract tasks Optum...
  • 36C26324D0041
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

The Department of Veterans Affairs (VA) Veterans Health Administration awarded a single-award Indefinite Delivery Contract (IDC) to Wells Pharma of Houston LLC, a for-profit limited liability company, to provide 503B compounding pharmaceuticals. The IDC has a ceiling value of $441,181 and a performance period through September 2025, with no set-aside designation.

As part of this IDC, the VA has issued two delivery orders to Wells Pharma: a $220,590.50 order in February 2024 and a $97,340.50 order in October 2024, both for 503B compounding pharmaceuticals. These delivery orders are in support of healthcare services for veterans integrated across the VA's Network 23, which covers the Houston, Texas area. Additionally, Wells Pharma holds a Blanket Purchase Agreement (BPA) with the Defense Health Agency for prefilled syringes, valued at $250,000 and effective through August 2028. These contract vehicles allow the VA and Defense Health Agency to procure pharmaceutical products as needed from Wells Pharma, establishing the company as a reliable long-term supplier of critical healthcare products to these federal agencies.

Generated 1/29/25, 9:09 AM